Roche Postdoctoral Fellow (RPF) in Oncology Discovery in Next-Generation Cell Therapy Urgent Hiring
The Position
Who we are:
At Roche, we believe it is urgent to deliver medical solutions right now - even as we develop innovations for the future. We are passionate about transforming patients’ lives and we are fearless in both making decisions and taking action.
That is why we come to work each day. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.
As a Postdoctoral Fellow in the Cancer Immunotherapy Department of Pharmaceutical Research and Early Development (pRED), you will conduct exploratory research projects with the aim to develop novel cell therapies for the treatment of cancer.
In this position you will:
- Conduct all steps needed to genetically engineer immune cells and characterize the resulting cell products in different assays
- You will be responsible to address all topics and perform all tasks that are necessary to successfully achieve the objectives of the RPF project
- You will execute the RPF project proactively with internal and external partners
- You will identify, develop and implement new technologies and assays
- You will generate results for high quality publications in peer reviewed journals
- Furthermore, you ensure that stay on top of current development in the field by attending (and presenting at) scientific meetings and interacting with the academic community
This position is sponsored by the Roche Postdoctoral Fellowship Programme.
The RPF Programme has the ambition to build and maintain the Scientific Leadership of the future and to provide leading Roche scientists with the opportunity to collaborate with talented postdoctoral researchers, and leading academic research groups, from around the world. One of the key aims is to advance basic science and technologies that will be published in top-rated, peer-reviewed scientific journals, if necessary preceded by priority patent applications.
The duration of RPF project is initially set for two years, with the possibility of extension for a third year. You will be based at the Roche Innovation Center Zurich.
Who you are/have:
- You hold a PhD or MD PhD degree in cancer biology, immunology, synthetic biology or related fields
- Deep understanding of immune cell engineering and/or cancer immunology
- You have hands on experience with functional assay development and optimization
- Proficiency with primary immune cell characterization techniques, hands-on experience in multi-colour flow cytometry
- Experience with gene editing technologies would be highly desirable
- Experience with in vivo experiments is a plus
- You are highly motivated and flexible to work on challenging frontline projects
- You are an excellent team player with the ability to work independently with exceptional planning, organizational skills
- Effective verbal and written communication skills
Moreover, you are/have:
You have very good interpersonal and communication skills, are able to build good working relationships, and are an outstanding teammate. Your experience and investigative attitude allow you to work independently, to design, perform, and interpret experiments, and to embark on new scientific methodologies.
- To be considered, please send us your complete application merged into one PDF including
- CV
- Motivation Letter
Roche embraces diversity and equal opportunity in a serious way. We are committed to building a team that represents a variety of backgrounds, perspectives, and skills. The more inclusive we are, the better our work will be.
If you still have questions, then please check our FAQs and videos on careers.roche.ch/faq
Tags: RPF pRED
More information about the RPF Programme: https://careers.roche.com/global/en/the-roche-postdoctoral-fellowship-programme
Roche ist ein Arbeitgeber, bei dem Chancengleichheit zählt.
Who we are
At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.
The Roche Innovation Center Zurich (Roche Glycart AG) is active in the research and development of engineered therapeutic antibodies, with a focus on the fields of cancer immunotherapy. Part of the Roche Group since 2005, it currently employs about 140 people. Read more.
We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.
Roche is an Equal Opportunity Employer.